Companies are embracing crypto treasury strategies, buying Bitcoin and Ethereum. 180 Life Sciences Corp shifts focus to Ethereum, rebrands as ETHZilla. Plans to raise $425 million through PIPE offering. Ethereum’s market cap is $463 billion, second only to Bitcoin. Ethereum used in DeFi, DAOs, gaming, and more.

180 Life Sciences financials show losses, no revenue generation. Operating losses at $1.73 million, cash balance $2.21 million. No analyst coverage on stock, investors wary of ETHZilla. Company’s poor financial track record discourages long-term investment. Consider direct investment in Ethereum for exposure to crypto.

Read more at Yahoo Finance: This Biotech Penny Stock Is Betting Big on Ethereum. Does Its Rapid Crypto Transformation Make It a Buy?